Helen Wildenauer

Helen Wildenauer is an accomplished Associate Scientist at Novo Nordisk since April 2023, with previous experience as an Assay Development Scientist at BluSense Diagnostics, where expertise included the development of diagnostic tests and automation of data analysis. Educational background encompasses a Master of Science and Bachelor of Science in Biochemistry from Freie Universität Berlin, complemented by diverse research roles at institutions such as DTU, Robert Koch Institute, and Freie Universität Berlin, focusing on antibody discovery, viral pathogenicity, and molecular techniques like NGS sequencing. Helen has demonstrated strong analytical skills through various research projects, including the use of phage display technology and live-cell microscopy.